| Drug Type siRNA | 
| Synonyms oligonucleotide-SPG complex, NJA 730, NJA-730A + [1] | 
| Target | 
| Action inhibitors | 
| Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors), Immunosuppressants, RNA interference | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPhase 1 | 
| First Approval Date- | 
| Regulation- | 


| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Graft vs Host Disease | Phase 1 | Australia  | 04 Nov 2018 | 





